Invention Grant
- Patent Title: Indazole derivatives useful as glucagon receptor antagonists
-
Application No.: US16242902Application Date: 2019-01-08
-
Publication No.: US10774048B2Publication Date: 2020-09-15
- Inventor: Guozhang Xu , Micheal Gaul , Shyh-Ming Yang , Tianbao Lu , Rui Zhang , Fengbin Song
- Applicant: JANSSEN PHARMACEUTICA NV
- Applicant Address: BE Beerse
- Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee Address: BE Beerse
- Agency: Arnall Golden Gregory LLP
- Main IPC: A61K31/416
- IPC: A61K31/416 ; C07D231/56 ; C07D401/06 ; C07D405/14 ; C07D405/04 ; C07D409/04 ; C07D403/04
Abstract:
The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.
Public/Granted literature
- US20190218186A1 INDAZOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS Public/Granted day:2019-07-18
Information query
IPC分类:
